A Q2 2024 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.6B-8.4% YoY

Gross Profit

$856M54.4% margin

Operating Income

$363M23.1% margin

Net Income

$308M19.6% margin

EPS (Diluted)

$1.05

QoQ Revenue Growth

-5.1%

Cash Flow

Operating Cash Flow

$333M

Free Cash Flow

$230M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$10.9B

Total Liabilities

$4.6B

Stockholders' Equity

$6.2B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.7B	-8.4%
Gross Profit	$856M	$924M	-7.4%
Operating Income	$363M	$383M	-5.2%
Net Income	$308M	$302M	+2.0%

Revenue Segments

Life Sciences and Applied Markets

$754M48%

Diagnostics and Genomics

$417M27%

Agilent CrossLab

$402M26%

Geographic Segments

Americas

$637M40%

Asia Pacific

$510M32%

Europe

$426M27%